Patients in whom heart failure (HF) or chronic kidney disease (CKD) is prevalent, should receive a treatment intensification with an SGLT-2 inhibitor with the respective evidence from clinical studies due to the respective data (7072)
Kidney Safety Explained by Doctor Glutathione May Actually Protect the Kidneys Where research points toward benefit, not harm Contrast-induced nephropathy (CIN): N-Acetyl Cysteine (NAC), a direct glutathione precursor, has been studied extensively as a protective agent in patients undergoing contrast imaging procedures with several trials reporting reduced markers of renal injury when NAC is administered before contrast exposure
Targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: safety and optimal dose selection in a randomized clinical trial
Discover how genetics and liver health influence acetaminophen metabolism and the risk of liver damage
How Our Liposomal Drug Encapsulation Services Workflow Works
In conclusion, long-term treatment with tesofensine led to significant weight loss in rats with diet-induced obesity